rs141620200

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_000295.5(SERPINA1):​c.922G>T​(p.Ala308Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0032 in 1,613,904 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A308T) has been classified as Benign.

Frequency

Genomes: 𝑓 0.0021 ( 3 hom., cov: 34)
Exomes 𝑓: 0.0033 ( 11 hom. )

Consequence

SERPINA1
NM_000295.5 missense

Scores

1
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:4

Conservation

PhyloP100: -0.142

Publications

23 publications found
Variant links:
Genes affected
SERPINA1 (HGNC:8941): (serpin family A member 1) The protein encoded by this gene is a serine protease inhibitor belonging to the serpin superfamily whose targets include elastase, plasmin, thrombin, trypsin, chymotrypsin, and plasminogen activator. This protein is produced in the liver, the bone marrow, by lymphocytic and monocytic cells in lymphoid tissue, and by the Paneth cells of the gut. Defects in this gene are associated with chronic obstructive pulmonary disease, emphysema, and chronic liver disease. Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Aug 2020]
SERPINA1 Gene-Disease associations (from GenCC):
  • alpha 1-antitrypsin deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Genomics England PanelApp, Orphanet, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • cystic fibrosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0059836507).
BP6
Variant 14-94379607-C-A is Benign according to our data. Variant chr14-94379607-C-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 288456.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00212 (322/152034) while in subpopulation NFE AF = 0.00399 (271/67956). AF 95% confidence interval is 0.0036. There are 3 homozygotes in GnomAd4. There are 159 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000295.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SERPINA1
NM_000295.5
MANE Select
c.922G>Tp.Ala308Ser
missense
Exon 4 of 5NP_000286.3
SERPINA1
NM_001002235.3
c.922G>Tp.Ala308Ser
missense
Exon 4 of 5NP_001002235.1E9KL23
SERPINA1
NM_001002236.3
c.922G>Tp.Ala308Ser
missense
Exon 6 of 7NP_001002236.1E9KL23

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SERPINA1
ENST00000393087.9
TSL:1 MANE Select
c.922G>Tp.Ala308Ser
missense
Exon 4 of 5ENSP00000376802.4P01009-1
SERPINA1
ENST00000355814.8
TSL:1
c.922G>Tp.Ala308Ser
missense
Exon 4 of 5ENSP00000348068.4P01009-1
SERPINA1
ENST00000393088.8
TSL:1
c.922G>Tp.Ala308Ser
missense
Exon 6 of 7ENSP00000376803.4P01009-1

Frequencies

GnomAD3 genomes
AF:
0.00212
AC:
322
AN:
151916
Hom.:
3
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000725
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000197
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00160
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00399
Gnomad OTH
AF:
0.000480
GnomAD2 exomes
AF:
0.00201
AC:
506
AN:
251208
AF XY:
0.00199
show subpopulations
Gnomad AFR exome
AF:
0.000616
Gnomad AMR exome
AF:
0.0000867
Gnomad ASJ exome
AF:
0.000894
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00208
Gnomad NFE exome
AF:
0.00374
Gnomad OTH exome
AF:
0.00228
GnomAD4 exome
AF:
0.00331
AC:
4840
AN:
1461870
Hom.:
11
Cov.:
31
AF XY:
0.00322
AC XY:
2343
AN XY:
727240
show subpopulations
African (AFR)
AF:
0.000538
AC:
18
AN:
33480
American (AMR)
AF:
0.0000671
AC:
3
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000803
AC:
21
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.00176
AC:
94
AN:
53402
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00410
AC:
4558
AN:
1112008
Other (OTH)
AF:
0.00242
AC:
146
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
280
560
840
1120
1400
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
184
368
552
736
920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00212
AC:
322
AN:
152034
Hom.:
3
Cov.:
34
AF XY:
0.00214
AC XY:
159
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.000723
AC:
30
AN:
41484
American (AMR)
AF:
0.000197
AC:
3
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4802
European-Finnish (FIN)
AF:
0.00160
AC:
17
AN:
10592
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00399
AC:
271
AN:
67956
Other (OTH)
AF:
0.000475
AC:
1
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
16
32
49
65
81
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00288
Hom.:
6
Bravo
AF:
0.00173
TwinsUK
AF:
0.00243
AC:
9
ALSPAC
AF:
0.00234
AC:
9
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00384
AC:
33
ExAC
AF:
0.00234
AC:
284
EpiCase
AF:
0.00273
EpiControl
AF:
0.00261

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
1
Alpha-1-antitrypsin deficiency (2)
-
1
1
not provided (2)
-
-
2
not specified (2)
-
1
-
SERPINA1-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
16
DANN
Benign
0.95
DEOGEN2
Benign
0.24
T
Eigen
Benign
-0.52
Eigen_PC
Benign
-0.54
FATHMM_MKL
Benign
0.22
N
LIST_S2
Benign
0.54
T
M_CAP
Benign
0.035
D
MetaRNN
Benign
0.0060
T
MetaSVM
Benign
-0.44
T
MutationAssessor
Uncertain
2.5
M
PhyloP100
-0.14
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-1.6
N
REVEL
Benign
0.27
Sift
Benign
0.065
T
Sift4G
Benign
0.40
T
Polyphen
0.0030
B
Vest4
0.44
MVP
0.99
MPC
0.059
ClinPred
0.014
T
GERP RS
3.4
Varity_R
0.47
gMVP
0.46
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141620200; hg19: chr14-94845944; API